What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
Kenneth E. Bernstein mainly investigates Angiotensin II, Internal medicine, Endocrinology, Angiotensin-converting enzyme and Molecular biology.
Kenneth E. Bernstein has included themes like Tyrosine kinase and Tyrosine phosphorylation in his Angiotensin II study.
His work on Kidney, Renin–angiotensin system and Endothelial dysfunction as part of general Internal medicine study is frequently linked to Vascular smooth muscle, bridging the gap between disciplines.
The Endocrinology study combines topics in areas such as Cardiology, Relative fluorescence units, Knockout mouse, Messenger RNA and Carboxypeptidase.
His Angiotensin-converting enzyme research incorporates themes from Endothelium, Isozyme, Enzyme and Bradykinin.
His work deals with themes such as Gene expression, Somatic cell, Gene, Gene targeting and Transcription, which intersect with Molecular biology.
His most cited work include:
- Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor (1131 citations)
- Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. (674 citations)
- Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility (404 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Angiotensin II, Internal medicine, Angiotensin-converting enzyme, Endocrinology and Renin–angiotensin system.
His Angiotensin II research includes themes of Cell biology and Tyrosine phosphorylation.
His studies deal with areas such as Diabetes mellitus and Cardiology as well as Internal medicine.
His studies in Angiotensin-converting enzyme integrate themes in fields like Molecular biology, Immune system, Pharmacology and Enzyme.
His Endocrinology research includes elements of Phenotype and Knockout mouse.
His Renin–angiotensin system research is multidisciplinary, relying on both Isozyme and Bradykinin.
He most often published in these fields:
- Angiotensin II (49.81%)
- Internal medicine (45.56%)
- Angiotensin-converting enzyme (44.79%)
What were the highlights of his more recent work (between 2016-2021)?
- Angiotensin-converting enzyme (44.79%)
- Angiotensin II (49.81%)
- Internal medicine (45.56%)
In recent papers he was focusing on the following fields of study:
Kenneth E. Bernstein focuses on Angiotensin-converting enzyme, Angiotensin II, Internal medicine, Endocrinology and Radiosurgery.
His Angiotensin-converting enzyme research is multidisciplinary, incorporating perspectives in Renin–angiotensin system, Immune system, Immunity and Pharmacology.
His study in Angiotensin II focuses on Angiotensin II receptor type 1 in particular.
His Angiotensin II receptor type 1 study incorporates themes from Candesartan, Molecular biology, Telmisartan and Superoxide.
Internal medicine is closely attributed to Protein kinase B in his work.
His study in Receptor extends to Endocrinology with its themes.
Between 2016 and 2021, his most popular works were:
- Angiotensin-converting enzyme in innate and adaptive immunity. (73 citations)
- Angiotensin-converting enzyme enhances the oxidative response and bactericidal activity of neutrophils (27 citations)
- Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study. (19 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- DNA
His primary scientific interests are in Angiotensin-converting enzyme, Angiotensin II, Internal medicine, ACE inhibitor and Pharmacology.
His Angiotensin II study integrates concerns from other disciplines, such as Tumor necrosis factor alpha, Ex vivo, In vitro, Renin–angiotensin system and Neuroinflammation.
His Renin–angiotensin system study combines topics from a wide range of disciplines, such as Acquired immune system, Transgene, Biochemistry, Enzyme and In vivo.
Kenneth E. Bernstein focuses mostly in the field of Internal medicine, narrowing it down to matters related to Endocrinology and, in some cases, Inflammation.
He combines subjects such as Reactive oxygen species, Microbiology, Molecular biology, Knockout mouse and Angiotensin II receptor type 1 with his study of ACE inhibitor.
Kenneth E. Bernstein interconnects Immunity, Major histocompatibility complex, MHC class II, Fibrosis and Macrophage in the investigation of issues within Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
